Embecta EMBC
NASDAQ EMBC
$5.61 +0.02 (+0.36%)
As of: Sep 23, 2026 · 10:06 AM EDT

Embecta (EMBC) Cost of Revenue (2020 - 2026)

Embecta's (EMBC) quarterly Cost of Revenue came in at $118.4 million in Q2 2026, up 20.33% year-over-year from $98.4 million in Q2 2025, and up 25.96% quarter-over-quarter from $94.0 million in Q1 2026.

Analysis

Embecta (EMBC) Cost of Revenue (2020 - 2026) Analysis & Trends

Embecta has disclosed Cost of Revenue across 7 years of filings, most recently posting $118.4 million for Q2 2026.

  • In Q2 2026, Cost of Revenue rose 20.33% year-over-year to $118.4 million; the TTM figure through Jun 2026 stood at $417.4 million (up 1.71% YoY), while the FY2025 annual figure was $403.6 million, up 4.05% from the prior year.
  • Cost of Revenue came in at $118.4 million for Q2 2026 at Embecta, up from $94.0 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $118.4 million in Q2 2026 to a low of $82.4 million in Q2 2024.
  • Average Cost of Revenue over 5 years is $96.9 million, with a median of $97.1 million recorded in 2022.
  • Year-over-year, Cost of Revenue slipped 14.7% in 2024 and increased 20.33% in 2026.
  • Over 5 years, Cost of Revenue stood at $86.9 million in 2022, then advanced by 5.18% to $91.4 million in 2023, then increased by 14.66% to $104.8 million in 2024, then declined by 5.06% to $99.5 million in 2025, then rose by 18.99% to $118.4 million in 2026.
  • Per Business Quant data, the three most recent Cost of Revenue figures were $118.4 million in Q2 2026, $94.0 million in Q1 2026, and $99.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Thermo Fisher Scientific 243.61 Bn 239.66 Bn 8.34 Bn 3.65 Bn
2 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn 5.33 Bn
3 Danaher 155.49 Bn 151.15 Bn 3.61 Bn 2.65 Bn
4 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn 931.90 Mn
5 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn 3.42 Bn
6 Stryker 105.51 Bn 102.03 Bn 4.50 Bn 2.09 Bn
7 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn 1.59 Bn
8 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn 392.40 Mn
9 Becton Dickinson 49.86 Bn 48.99 Bn 2.32 Bn 2.67 Bn
10 Embecta 316.73 Mn 98.53 Mn 153.30 Mn 118.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 118.40 Mn
Mar 31, 2026 94.00 Mn
Dec 31, 2025 99.50 Mn
Sep 30, 2025 105.50 Mn
Jun 30, 2025 98.40 Mn
Mar 31, 2025 94.90 Mn
Dec 31, 2024 104.80 Mn
Sep 30, 2024 112.30 Mn
Jun 30, 2024 82.40 Mn
Mar 31, 2024 101.80 Mn
Dec 31, 2023 91.40 Mn
Sep 30, 2023 100.10 Mn
Jun 30, 2023 96.60 Mn
Mar 31, 2023 87.30 Mn
Dec 31, 2022 86.90 Mn
Sep 30, 2022 97.70 Mn
Jun 30, 2022 88.20 Mn
Mar 31, 2022 83.30 Mn
Dec 31, 2021 85.40 Mn
Sep 30, 2021 90.60 Mn
API Access

Embecta Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=EMBC&period=max&api_key=YOUR_API_KEY